Concepedia
Statistics
Publications
38
Citations
2.1K
H-Index
20
Active since
1984
Affiliations
Showa Pharmaceutical University(Current)
Shin Nippon Biomedical Laboratories (Japan)
Central Institute for Experimental Animals
Keio University
Shin Nippon Biomedical Laboratories (United States)
Masahiro Utoh is an author at Showa Pharmaceutical University specializing in pharmacology, medicine, and cytochrome p450 enzymes.
Publications per year
1984–2017
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients
Johannes Sch�ller, Jim Cassidy, Étienne Dumont et al. · Cancer Chemotherapy and Pharmacology · 2000 · 666 citations
Medicine, Oncology, Pharmacology +14
Tumor Selective Delivery of 5-Fluorouracil by Capecitabine, a New Oral Fluoropyrimidine Carbamate, in Human Cancer Xenografts
Tohru Ishikawa, Masahiro Utoh, Noriaki Sawada et al. · Biochemical Pharmacology · 1998 · 330 citations
Medicine, Oncology, Pharmacology +16
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
Bruno Reigner, Jaco J. Verweij, Luc Dirix et al. · PubMed · 1998 · 161 citations
Pharmacy, Pharmacokinetics, Pharmacology +17
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.
Chris Twelves, Rob Glynne‐Jones, Jim Cassidy et al. · PubMed · 1999 · 158 citations
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients
Bruno Reigner, Saly Clive, Jim Cassidy et al. · Cancer Chemotherapy and Pharmacology · 1999 · 70 citations
Medicine, Pharmacokinetics, Pharmacology +14
1–5 of 38